OKYO Pharma
OKYO----
OKYO Pharma (OKYO)
OKYO Pharma Limited, a clinical-stage biopharmaceutical company, develops therapeutics for patients suffering from inflammatory eye diseases and ocular pain in...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
OKYO Pharma Analyst Rating
View MoreForecast & Rating
Jul 20, 2026Price forecast
$8.33437.63%
Forecast & RatingStrong buy
3analysts
- Strong buy66.67%
- Buy33.33%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- Tip Ranks · 1 day ago, 11:27 AM
OKYO Pharma Director Ups Stake Ahead of Planned Phase 3 Neuropathic Corneal Pain Trial
- Unusual Whales · 1 day ago, 06:02 AM
OKYO Pharma Announces Purchase of Shares by Chief Executive Officer
- StockTitan · 1 day ago, 03:00 AM
OKYO Pharma Announces Purchase of Shares by Director | OKYO Stock News
- Tip Ranks · 2 days ago, 09:27 AM
OKYO Pharma Executive Boosts Shareholding Ahead of Planned Phase 3 NCP Trial
- StockTitan · 2 days ago, 01:00 AM
OKYO Pharma Announces Purchase of Shares by Chief Development Officer and Director | OKYO Stock News
- Tip Ranks · Jul 21 at 08:30 AM
OKYO Pharma to Present Ophthalmology Pipeline Ahead of Phase 3 Urcosimod Trial
